Adrian Woolfson, BM BCh, Ph.D., has been appointed executive vice president of R&D, Sangamo Therapeutics, Inc. Dr. Woolfson will oversee discovery, research and development activities for the company and will report to Sandy Macrae. Dr. Woolfson has over a decade of biopharmaceutical industry experience in drug discovery, medical affairs and early and late stage clinical development. Most recently, he served as chief medical officer at Nouscom AG, a genetic cancer vaccine biotechnology co...